To include your compound in the COVID-19 Resource Center, submit it here.

Neos Therapeutics sales and marketing update

Neos launched once-daily Adzenys XR-ODT amphetamine in the U.S. to treat ADHD

Read the full 127 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE